Skip to content

Advertisement

  • Research
  • Open Access

Association of tryptophan hydroxylase-2 polymorphisms with oppositional defiant disorder in a Chinese Han population

  • †1,
  • †1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • †1Email author and
  • †2Email author
†Contributed equally
Behavioral and Brain Functions201612:30

https://doi.org/10.1186/s12993-016-0113-0

©  The Author(s) 2016

  • Received: 13 June 2016
  • Accepted: 4 November 2016
  • Published:

Abstract

Background

Oppositional defiant disorder (ODD) is a behavioral disorder of school-age population. It is well known that 5-HT dysfunction is correlated with impulsivity, which is one of the common characteristics of ODD. The enzyme tryptophan hydroxylase-2 (TPH-2) synthesizes 5-HT in serotonergic neurons of the midbrain raphe. The purposes of this study were to investigate the potential association of TPH-2 polymorphisms with susceptibility to ODD in a Han Chinese school population.

Methods

Four polymorphisms (rs4570625, rs11178997, rs1386494 and rs7305115) of the TPH-2 gene were analyzed by using polymerase chain reaction and DNA microarray hybridization in a case–control study of 276 Han Chinese individuals (124 ODD and 152 controls).

Results

In single marker analyses,there was a significant difference in the genotype (χ 2  = 4.163, P = 0.041) and allele frequency (χ 2  = 3.930, P = 0.047) of rs1386494 between ODD and control groups. Haplotype analyses revealed higher frequencies of haplotypes TA (rs4570625-rs11178997), TAG (rs4570625-rs11178997-rs1386494), TAA (rs4570625-rs11178997-rs7305115) and TAGA (rs4570625-rs11178997-rs1386494-rs7305115), but lower frequencies of haplotypes GA (rs4570625-rs11178997) and GAG (rs4570625-rs11178997-rs1386494) in ODD compared to control groups.

Conclusions

These findings suggest the role of these TPH-2 gene variants in susceptibility to ODD. Some haplotypes might be the risk factors for Chinese Han children with ODD, while others might be preventable factors.

Keywords

  • Oppositional defiant disorder
  • Tryptophan hydroxylase-2 gene
  • Single nucleotide polymorphisms

Background

Oppositional defiant disorder (ODD) is a behavioral disorder mainly characterized by resistance, disobedience, provocation or hostility to authority figures during growth and development in children and adolescents [1, 2]. Children and adolescents with ODD may have trouble controlling their temper, showing intense emotional reaction or impulsive actions in response to mild stimulation. Thus, ODD is considered as a disorder of emotional regulation [3]. Children suffering from ODD are at risk for numerous negative outcomes, such as delinquency, unemployment, depression, anxiety and other psychiatric problems [4]. However, the pathological mechanisms of ODD are still unclear.

Based on DSM-IV-TR, the prevalence rate for ODD is 2–16% [5]. Well established in previous research, this disorder exhibits moderate heritability, and is substantially stable over time, particularly through childhood [6], and genetic underpinning is an important factor which can influence children’s disruptive behavior, like ODD [7]. Familial clustering suggests an underlying genetic component, but hereditary connections are variable [1]. ODD has been consistently associated with attention-deficit/hyperactivity disorder (ADHD) [8, 9] and conduct disorder (CD) [10–13]. The estimated heritability of ADHD is approximately 0.76 [14] and 40–60% of ADHD were also diagnosed with ODD [15], suggesting that ODD might share common genetic mechanisms with ADHD [8]. However, the comorbidity of ODD may influence the clinical characteristics, progression and treatment response for ADHD cases [14].

Serotonin (5-HT) is a neurotransmitter involved in various bodily functions, such as aggression, attention, appetite and locomotion. The deficiency of the 5-HT functions is related to depression, anxiety, irregular appetite, aggression, increased pain sensation, and ADHD symptoms [16]. Especially, 5-HT dysfunction is correlated with impulsivity, which is one of the common characteristics of ADHD, ODD, personality disorder [17] and substance abuse [18, 19]. Early studies reported a clear association between low cerebrospinal fluid 5-HT and impulsive aggression [20]. The conversion of tryptophan to 5-hydroxytryptophan is the first and rate limiting step in 5-HT synthesis catalyzed by two subtypes of the enzyme tryptophan hydroxylase (TPH-1 and TPH-2); 5-HT is then formed by decarboxylation of 5-hydroxytryptophan. The studies revealed differential expression of classical TPH-1 synthesizing 5-HT in peripheral tissues, and TPH-2 synthesizing 5-HT mainly in serotonergic neurons of the midbrain raphe [21]. In mice brain stems, the expression of TPH-1 appears to be 150 times lower than TPH-2 [21], suggesting that TPH-2 may play a much more important role in serotonin synthesis in the brain than TPH-1. Thus, the studies have focused on the role of brain-specific TPH-2 in the pathophysiology of various psychiatric disorders, including ADHD [16].

The human TPH-2 gene spans less than 100 kb, consists of 11 exons and is located in the chromosome 12q21.1 region. Several studies have explored the association between TPH-2 gene polymorphisms and ADHD. For example, Sheehan et al. [22] firstly reported the association between TPH2-rs1843809 and ADHD through a family study. A subsequent study reported association between TPH2-rs4570625 or TPH2-rs11178997 and ADHD through a family study [23]. A more recent study showed that a significant correlation between the frequencies of the rs11179027 and rs1843809 of alleles of TPH-2 and ADHD [16]. In addition, the TPH-2 gene polymorphism have been found to be associated with late-onset depression [24], PTSD [25, 26], suicide in patients with alcohol dependence [27, 28] and suicidal behavior [29], as well as with schizophrenia [30, 31] and panic in bipolar disorders [32] in the Chinese Han population.

In view of the possible shared common genes between ADHD and ODD, the important role of TPH-2 in 5-HT synthesis in brain and the possible association between TPH-2 gene polymorphisms and ADHD, as well as the associations of the TPH-2 gene polymorphism with behavioral and psychiatric disorders in previous studies, it would be of interest to examine the association between TPH-2 gene polymorphisms and ODD, which, to our best knowledge, has not been reported. Therefore, the main purpose of the current study was to examine whether the TPH-2 gene polymorphisms was associated with the susceptibility to ODD in a Chinese Han population.

Methods

Subjects

Using the random group sampling method, 2000 Chinese Han students in primary school in Nanyang, Henan Province, China were assessed with Conners Teachers Rating Scale between 2007 and 2009, all four grandparents and both parents of each child were known to be of Han Chinese origin. To confirm the diagnosis of ODD, one or both parents and teachers were interviewed by a chief physician and resident physician on the basis of DSM-IV diagnostic criteria. Inclusion criteria were: (a) aged 6–14 years; (b) had ODD symptoms at least 6 months; (c) intelligence quotient (IQ) ≥70 based on Raven’s Progressive Matrices; (d) no physical diseases, mental retardation, low body mass index (BMI, <18.5 kg/m2) or other mental illnesses, or ADHD or CD symptoms. A total of 125 children were confirmed with ODD diagnosis. Among them, 124 subjects were enrolled in the study, including 70 boys (56.5%) and 54 girls (43.5%) with an average age of 10.4 ± 1.9 years.

Data also consisted of 152 control subjects (boy/girl = 78/74), who were recruited from the same primary school. Mean age was 10.5 ± 1.6 years. Inclusion criteria were: (a) aged 6–14 years; (b) no any ODD symptoms; (c) intelligence quotient (IQ) ≥70 based on Raven’s Progressive Matrices; (d) no physical diseases, mental retardation, low body mass index (BMI, <18.5 kg/m2) or other mental illnesses, or ADHD or CD symptoms.

There was no significant differences in gender, age and education between ODD and control groups (all P > 0.05). This study was approved by the Ethical Committee of the Second Affiliated Hospital, Xinxiang Medical College, Henan Province. Informed consent was obtained from all subjects and their parents.

TPH-2 genotyping

5 ml blood samples were collected from cubital vein between 8:00 and 9:00 a. m. following an overnight fast and placed into the tubes with EDTA anticoagulant. Samples were stored at −70 °C until assayed.

DNA was extracted using a Genomic DNA extraction kit (DP318) (TIANGEN biotechnology company, Beijing, China). The DNA was amplified by polymerase chain reaction (PCR) methods and the primers for the four loci (rs4570625, rs11178997, rs1386494 and rs7305115) were designed by Invitrogen Corporation (Shanghai, China). Oligonucleotide sequences are presented in Table 1.
Table 1

Primer sequences of these four loci

SNP ID

Primer sequence (5′–3′)

rs4570625

F: 5′-GAACCCTTACCTTTCCTTTG-3′

R: 5′Acry-TCCACTCTTCCAGTTATTTT-3′

rs11178997

F: 5′-GTGTTCGGGAGCACAATAAT-3′

R: 5′ Acry -AAGCCTGCCACTGGAAGTT-3′

rs1386494

F: 5′-TGTTTCTCGCAGGTTGTTGG-3′

R: 5′ Acry-AGCAAATGAATCACAAAGGG-3′

rs7305115

F: 5′-TAGTTGGTTTTTCTGTTGC-3′

R: 5′Acry-CCCTTTTCTCTTTAGGTGAG-3′

Sequences of the four primers

The total volume of the PCR reaction was 30 μl which contained 0.5 μl whole genome DNA (50 ng/μl), 3 μl 10× PCR buffer solution, 0.5 μl 10 mm L−1 dNTPs, 0.5 μl each primer, 0.3 μl Taq polymerase, 1.5 μl 25 mm L−1 MgCl2, and 23.7 μl sterile water. Loop parameters for PCR were as follows: initial denaturation at 95 °C for 5 min, amplification at 94 °C for 30 s, annealing at 54/56 °C for 45 s, and extension at 72 °C for 45 s. The process was repeated 34 times, followed by extension at 72 °C for 5 min. PCR products were placed onto glass slides disposed with acrylamide by a Pixsys5500 microarrayer (Cartesian Products, Inc. America) [33]. The PCR products were hybridized with fluorescence-labeled probes at 37 °C for 5–6 h, and the glass slides were scanned with a LuxScan-10k confocal scanner (Capitalbio Corporation, Beijing, China). The genotype of each sample was detected based on the fluorescent signals [34].

Statistical analysis

Differences between genotype groups were analyzed using Chi squared for categorical variables and the Student’s t test or one-way analysis of variance (ANOVA) for continuous variables using the PASW Statistics 18.0 software (SPSS Inc., Chicago, IL, USA).

Deviation from the Hardy–Weinberg equilibrium (HWE) was tested separately in cases and controls using Chi square (χ 2 ) goodness-of-fit test. The difference in the allele and genotype frequencies for TPH-2 polymorphisms between ODD and normal controls was analyzed using the χ 2 test. Pairwise linkage disequilibrium (LD) between four TPH-2 markers was analyzed in cases and normal controls. Haploview 4.2 was used to compute pairwise LD statistics for markers, haplotype block, haplotype frequency, and haplotype association. We used a 2–4-window fashion analysis. Rare haplotypes found in less than 3% were excluded from the association analysis. A logistic regression analysis was conducted to examine the independent association of each haplotype on the categorical diagnosis of case (0: control, 1: case) after adjusting for the confounders. To control haplotype analyses for multiple testing, 10,000 permutations were performed for the most significant tests to determine the empirical significance.

The power (power defined as the chance that true differences will actually be detected) of the sample was calculated using Quanto Software [35], with known risk allele frequencies and an ODD population prevalence of 0.02–0.16, and we examined log additive, recessive and dominant models.

Results

Single locus analysis

The genotype and allele frequencies of four SNPs located in the TPH-2 gene are summarized in Table 6. No deviation from HWE was detected in the cases or controls (all P > 0.05; Tables 2, 3, 4, 5). Significant differences in the genotype and allele frequencies between cases and controls were observed for rs1386494 (genotype χ 2  = 4.163, P = 0.041; allele χ 2  = 3.930, P = 0.047). The frequency of the Gallele of rs1386494 was higher in patients than in controls. There was no allelic or genotypic association between the other three SNPs and ODD (all P > 0.05, Table 6).
Table 2

rs4570625 Hardy–Weinberg Equilibrium test between ODD and control group

Group

Genotype

GG

GT

TT

Total

χ2

P

ODD group

    

1.474

0.225

Observation (O)

27

51

38

116

  

Expectation (E)

23.761

57.478

34.761

116

  

Control group

    

1.301

0.254

Observation (O)

36

83

33

152

  

Expectation (E)

39.515

75.970

36.51

152

  

df = 1

Table 3

rs11178997 Hardy–Weinberg equilibrium test between ODD and control group

Group

Genotype

AA

AT

TT

Total

χ2

χ2*

P

ODD group

     

1.292

0.256

 Observation (O)

6

33

84

123

   

 Expectation (E)

4.116*

36.768

82.116

123

   

Control group

     

0.052

0.820

 Observation (O)

4

39

109

152

   

 Expectation (E)

3.633*

39.734

108.63

152

   

df = 1, when E is little than 5, we use Yates corrected Chi squared test, χ2*

Table 4

rs1386494 Hardy–Weinberg equilibrium test between ODD and control group

Group

Genotype

AA

AG

GG

Total

χ2

χ2*

P

ODD group

     

0.138

0.711

 Observation (O)

0

8

116

124

   

 Expectation (E)

0.129*

7.742

116.129

124

   

Control group

     

0.856

0.355

 Observation (O)

0

21

128

149

   

 Expectation (E)

0.740*

19.520

128.740

149

   

df = 1* when E is little than 5, we use Yates corrected Chi squared test, χ2*

Table 5

rs7305115 Hardy–Weinberg equilibrium test between ODD and control group

Group

AA

AG

GG

Total

χ2

P

ODD group

    

3.389

0.533

 Observation (O)

34

56

29

119

  

 Expectation (E)

32.303

59.395

27.302

119

  

Control group

    

0.844

0.358

 Observation (O)

35

64

40

139

  

 Expectation (E)

2.295

69.410

37.295

139

  

df = 1

Table 6

Genotype and allele frequency distribution of the four loci of THP-2 between two groups

Locus

Genotype (%)

χ 2

P

Allele (%)

χ 2

P

rs4570625

GG

GT

TT

4.525

0.104

G

T

1.729

0.189

ODD

27 (23.3)

51 (44.0)

38 (32.8)

105 (45.3)

127 (54.7)

Control

36 (23.7)

83 (54.6)

33 (21.7)

155 (51.0)

149 (49.0)

rs11178997

AA

AT

TT

1.092

0.579

A

T

0.783

0.376

ODD

6 (4.9)

33 (26.8)

84 (68.3)

45 (18.3)

201 (81.7)

Control

4 (2.6)

39 (25.7)

109 (71.7)

47 (15.5)

257 (84.5)

rs1386494

AA

AG

GG

4.163

0.041*

A

G

3.930

0.047*

ODD

0

8 (6.5)

116 (93.5)

8 (3.2)

240 (96.8)

Control

0

21 (14.1)

128 (85.9)

21 (7.0)

277 (93.0)

rs7305115

AA

AG

GG

0.756

0.685

A

G

0.780

0.377

ODD

34 (28.6)

56 (47.1)

29 (24.4)

124 (52.1)

114 (47.9)

Control

35 (25.2)

64 (46.0)

40 (28.8)

134 (48.2)

144 (51.8)

* P<0.05

Linkage disequilibrium (LD) analysis

LD analyses were performed for all polymorphism pairs in both case and control subjects. All four polymorphisms were in slight to modest LD or without LD with each other in both control (D′ = 0.12–0.92; r2 = 0.02–0.71) and patient groups (D′ = 0.10–0.76; r2 = 0.00–0.16) (Fig. 1).
Fig. 1
Fig. 1

Genomic structure of TPH-2, including relative location of 4 SNPs studied and linkage disequilibrium (LD) of these four SNPs in the oppositional defiant disorder (ODD) and control groups. The LD between pairwise SNPs, using D′ (left, red color) and r2 (right, gray color) values, are shown separately for cases and controls. High levels of LD are represented by increasing scale intensity from 0 to 100, as shown by the bars

Haplotype analysis

Two–four SNP sliding window haplotype analyses were performed. Only those haplotypes with a frequency above 3% were included in the analyses. Estimation of haplotype frequencies and comparison of haplotype frequency distributions between cases and controls were conducted using the program Haploview.

We observed significant differences in the frequencies of TA (P = 0.014, OR = 1.951, 95% CI 1.140–3.341) and GA (P = 0.012, OR = 0.149, 95% CI 0.027–0.826) haplotypes containing rs4570625-rs11178997 between case and control groups.

Also, we noted significant differences in the frequencies of TAG (P = 0.02, OR = 1.896, 95% CI 1.099–3.272) and GAG (P = 0.013, OR = 0.149, 95% CI 0.027–0.831) containing rs4570625-rs11178997-rs1386494, as well as TAA (P = 0.026, OR = 2.315, 95% CI 1.088–4.927) containing rs4570625-rs11178997-rs7305115 between case and control groups.

Finally, we found significant differences in the frequencies of TAGA (P = 0.005, OR = 3.187, 95% CI 1.376–7.382) containing rs4570625-rs11178997-rs1386494-rs7305115 between ODD and control groups (Tables 7, 8).
Table 7

Analysis of genetic linkage disequilibrium of the four loci

SNPs

SNP2

SNP3

SNP4

D′

r2

D′

r2

D′

r2

SNP1

0.702

0.090

0.093

0.001

0.405

0.161

SNP2

  

0.653

0.005

0.001

0.000

SNP3

    

0.887

0.049

SNP1:rs4570625; SNP2:rs11178997; SNP3:rs1386494; SNP4:rs7305115

Table 8

Haplotype analysis of TPH-2 between two groups

Haplotype distribution

Case (freq)

Control (freq)

χ 2

Fisher P

OR [95% CI]

SNP1-2

 G-A

1.52 (0.007)

10.57 (0.042)

6.281

0.012233*

0.149 [0.027–0.826]

 T-A

40.48 (0.174)

24.43 (0.098)

6.083

0.013679*

1.951 [1.140–3.341]

SNP1-2-3

 G-A-G

1.51 (0.007)

10.51 (0.042)

6.234

0.012562*

0.149 [0.027–0.831]

 T-A-G

38.73 (0.167)

24.00 (0.096)

5.409

0.020075*

1.896 [1.099–3.272]

SNP1-2-4

 T-A-A

22.24 (0.096)

10.60 (0.042)

4.981

0.025669*

2.315 [1.088–4.927]

SNP1-2-3-4

 T-A-G-A

21.77 (0.094)

7.79 (0.031)

8.031

0.004617*

3.187 [1.376–7.382]

SNP1:rs4570625; SNP2:rs11178997; SNP3:rs1386494; SNP4:rs7305115 * P<0.05

However, the further analysis by Haploview revealed the nominally significant finding for rs1386494 (χ 2  = 3.846, P = 0.0499), and only one haplotypes (TAGA, χ 2  = 4.366, P = 0.0367) remained significant. However, the results did not remain statistically significant after 5000-fold permutation-based analysis incorporating all four SNPs or all the observed haplotypes (adjusted both P > 0.14). Thus, our study was only considered as preliminary evidence of a possible association.

Power analysis

This total sample had 0.10–0.47 power, 0.31–0.70 power, and 0.36–0.97 power for these four polymorphisms to detect recessive, log additive and dominant polymorphic inheritance in ODD with an odds ratio (OR) of 2 or greater (alpha = 0.05, two tailed test).

Discussion

To our knowledge, this is the first study to find an association between ODD and the TPH-2 gene polymorphism rs1386494 or the haplotype formed by this polymorphism and other polymorphisms. While most TPH-2 association studies have used individual markers, we used polymorphism-based haplotypes and LD analysis to show that both ODD and controls shared a homogeneous LD pattern. This LD suggests that these variants segregate together in a Chinese population.

There is an extensive data consistently showing that decreased functions of the central 5-HT activity are associated with uncontrolled behaviors, including impulsive behavior, aggressiveness, and substance abuse both in humans and in animal models, for example [29, 36, 37]. TPH-2, a rate-limiting enzyme in the biosynthesis of 5-HT, is expressed mainly in brain [38]; thus, it influences the 5-HT level in brain and plays an important role in the development of mental disease [16]. Genetic variation in TPH-2 activity is likely to represent a critical factor in the pathogenesis of ADHD and impulsivity [16, 23]. Several studies have demonstrated that changes in the 5-HT system were critical in children with ODD [39, 40]. Moreover, the polymorphisms of TPH-2 have been shown to be associated with ADHD [16, 41, 42], obsessive–compulsive disorder [43], and bipolar affective disorder [44]. Also, TPH-2 was found to be associated with major depression [45] and pathogenesis of depression in Chinese females [46] and suicidal behavior [47, 48]. However, there has been no study reporting the relationship between TPH-2 and ODD.

This study is a case–controlled study in which the frequency of the genotypes and alleles of TPH-2 polymorphisms were compared between the ODD children and the control group in Chinese Han. The association between the genotypes and alleles of four candidates TPH-2 SNPs was investigated. Our results showed that there was a significant correlation between the frequencies of the TPH-2-rs1386494 and ODD, but not other three polymorphisms, suggesting that the locus of rs1386494 of TPH-2 was associated with ODD in Chinese Han children. The association of TPH-2-rs1386494 in this study was inconsistent with the result of Walitza et al. [23] study, in which loci of rs4570625 and rs11178997 were found to be associated with ADHD and combined ADHD and ODD, but not rs4565946. There are several reasons to explain the inconsistent results. First, the subjects in Walitza’s study included both ADHD and ODD. Second, the linkage disequilibrium analysis in the core family was used in Walitza’s study while the case-control association was used in several studies including our current study. Thus, the differential analysis methods and different samples may contribute to discrepant results.

Haplotypes can be more specific risk markers than single alleles, and their use reduces false-positive associations that can occur because common psychiatric disorders are likely to associate with common alleles [49]. Since the four markers analyzed were in the same haplotype block, we performed the two–four SNP sliding window haplotype analysis [50]. We found that the frequencies of the TA and GA haplotypes containing rs4570625-rs11178997, the TAG and GAG haplotypes containing rs4570625-rs11178997-rs1386494, the TAA haplotype containing rs4570625-rs11178997-rs7305115, and the TAGA haplotype containing rs4570625-rs11178997-rs1386494-rs7305115 were significantly different between ODD and controls (all P < 0.05). Further, TA, TAG, TAA and TAGA haplotypes might be the risk factors for ODD, while GA and GAG haplotypes might be protective for ODD in Chinese Han children.

Several limitations of this study should be noted. First, the number of subject children was small. The subjects of this study were 124 ODD children and 152 children in the control group. Since our sample size provided only poor statistical power, it is possible that we do see the false-positive results in the present study and our findings need to be considered cautiously. A replication study would be needed to include a large sample size. Second, although we had genotyped four polymorphisms in the present study, the coverage of genetic variation is too limited considering the total TPH-2 gene variants includes at least 50 polymorphisms. Therefore, it would be much better to use GWAS in larger samples to capture true positive results found in our present study. Third, the samples in our current study were only from local city in Henan province, China. Thus, the findings of this study may not be generalized for the cases of other racial or ethnic groups since the frequency of alleles can vary due to local or racial differences. Fourth, it would be better to use DSM-V as a reference rather than DSM-IV. Unfortunately, we had no DSM-V when our current study was conducted. We will use DSM-V as a reference in our future investigation to remedy this shortcoming.

In summary, we report several convergent findings that implicate an effect of TPH-2 genotype on increased risk for ODD. We found a potential genetic association of TPH-2 with risk for ODD, especially the TPH-2 gene polymorphism rs1386494. Further haplotype analyses showed that TA, TAG, TAA and TAGA haplotypes might be the risk factors for ODD, while GA and GAG haplotypes might be protective for ODD in Chinese Han children. However, the findings in our present study remain preliminary due to the limited sample size and our low statistical power, as well as poor coverage of genetic variations in THP-2, which require replication in larger samples of ODD children from different ethnic populations.

Notes

Abbreviations

ODD: 

oppositional defiant disorder

CD: 

conduct disorder

ADHD: 

attention-deficit/hyperactivity disorder

TPH-2 : 

the tryptophan hydroxylase-2 gene

5-HT: 

serotonin

IQ: 

intelligence quotient

PCR: 

polymerase chain reaction

SNP: 

single nucleotide polymorphisms

Declarations

Authors’ contributions

C-HW and CL contributed equally for this study and are both considered as first authors, they created the design of the study and the experimental paradigm, managed the acquisition of the data, analyzed and interpreted the data, and wrote the first draft. E-ZC, G-LX and T-TL has been involved in collecting study subjects. Y-LZ did the guidance of laboratory methods in this study, Q-FN managed the acquisition of the data, analyzed and interpreted the data as an assistant, J-KW has been involved in drafting and revising the manuscript. YL and H-YN are the corresponding authors and have contributed equally to this work. All authors read and approved the final manuscript.

Acknowledgements

We warmly thank the children and their parents who kindly took part in this research, as well as the schools and the teachers who agreed to collaborate in this study. We warmly thank Xiang Yang Zhang to help us modify our language errors.

Competing interests

The related authorities and the authors declare that they all have no competing interest. The authors declare that the research was conducted in the absence of any commercial, financial (and non-financial) relationships that could be construed as a potential competing interests.

Consent for publication

We have obtained the informed consent for publication from the children’s parents or legal guardian.

Ethics approval and consent to participate

Research programs “Association of tryptophan hydroxylase-2 polymorphisms with oppositional defiant disorder in a Chinese Han population” have been investigated by medical ethics committee of The second affiliated hospital of Xinxiang Medical University, which result was agreement (Batch number: 20090108).

Funding

This work was supported by grants from the Medical Technology Foundation of Henan Province (142300410025 and 112102310211), Scientific Research Fund of Xinxiang Medical University (2013ZD117) and Ministry of Health research fund projects in China (20090103). Henan Provincial Department of Science and Technology Research Project (102101310400).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Psychiatry, The Second Affiliated Hospital of Xinxiang Medical University (Psychiatric hospital of Henan province, China), Xinxiang, 453002, Henan, China
(2)
Department of Child and Adolescent, Public Health College, Zhengzhou University, 100 Kexue Road, Zhengzhou, 450001, Henan, China

References

  1. Riley M, Ahmed S, Locke A. Common questions about oppositional defiant disorder. Am Fam Physician. 2016;93(7):586–91.PubMedGoogle Scholar
  2. Frick PJ, Nigg JT. Current issues in the diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder. Annu Rev Clin Psychol. 2012;8:77–107. doi:10.1146/annurev-clinpsy-032511-143150.View ArticlePubMedGoogle Scholar
  3. Cavanagh M, Quinn D, Duncan D, Graham T, Balbuena L. Oppositional defiant disorder is better conceptualized as a disorder of emotional regulation. J Atten Disord. 2014;[Epub ahead of print]. doi:10.1177/1087054713520221.
  4. Bradshaw CP, Schaeffer CM, Petras H, Ialongo N. Predicting negative life outcomes from early aggressive-disruptive behavior trajectories: gender differences in maladaptation across life domains. J Youth Adolesc. 2010;39(8):953–66. doi:10.1007/s10964-009-9442-8.View ArticlePubMedGoogle Scholar
  5. Gomez R, Hafetz N, Gomez RM. Oppositional defiant disorder: prevalence based on parent and teacher ratings of Malaysian primary school children. Asian J Psychiatry. 2013;6(4):299–302. doi:10.1016/j.ajp.2013.01.008.View ArticleGoogle Scholar
  6. Pihlakoski L, Sourander A, Aromaa M, Rautava P, Helenius H, Sillanpää M. The continuity of psychopathology from early childhood to preadolescence: a prospective cohort study of 3 to 12-year-old children. Eur Child Adolesc Psychiatry. 2006;15(7):409–17. doi:10.1007/s00787-006-0548-1.View ArticlePubMedGoogle Scholar
  7. Burke JD, Loeber R, Birmaher B. Oppositional defiant disorder and conduct disorder: a review of the past 10 years, part II. J Am Acad Child Adolesc Psychiatry. 2002;41:1275–93. doi:10.1097/01.CHI.0000024839.60748.E8.View ArticlePubMedGoogle Scholar
  8. Tuvblad C, Zheng M, Raine A, Baker LA. A common genetic factor explains the covariation among ADHD ODD and CD symptoms in 9–10 year old boys and girls. J Abnorm Child Psychol. 2009;37(2):153–67. doi:10.1007/s10802-008-9278-9.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Gopin CB, Berwid O, Marks DJ, Mlodnicka A, Halperin JM. ADHD preschoolers with and without ODD: do they act differently depending on degree of task engagement/reward? J Atten Disord. 2013;17(7):608–19. doi:10.1177/1087054711432140.View ArticlePubMedGoogle Scholar
  10. Liu L, Cheng J, Li H, Yang L, Qian Q, Wang Y. The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. J Child Psychol Psychiatry. 2015;56(1):58–66. doi:10.1111/jcpp.12278.View ArticlePubMedGoogle Scholar
  11. Rowe R, Costello EJ, Angold A, Copeland WE, Maughan B. Developmental pathways in oppositional defiant disorder and conduct disorder. J Abnorm Psychol. 2010;119(4):726–38. doi:10.1037/a0020798.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Coolidge FL, Thede LL, Young SE. Heritability and the comorbidity of attention deficit hyperactivity disorder with behavioral disorders and executive function deficits: a preliminary investigation. Dev Neuropsychol. 2000;17(3):273–87. doi:10.1207/s15326942dn1703_1.View ArticlePubMedGoogle Scholar
  13. Lahey BB, Waldman ID. Annual research review: phenotypic and causal structure of conduct disorder in the broader context of prevalent forms of psychopathology. J Child Psychol Psychiatry. 2012;53(5):536–57. doi:10.1111/j.1469-7610.2011.02509.x.View ArticlePubMedGoogle Scholar
  14. Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 2010;33(1):159–80. doi:10.1016/j.psc.2009.12.004.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany. J Child Adolesc Psychopharmacol. 2011;21(2):97–110. doi:10.1089/cap.2009.0111.View ArticlePubMedGoogle Scholar
  16. Park TW, Park YH, Kwon HJ, Lim MH. Association between TPH2 gene polymorphisms and attention deficit hyperactivity disorder in Korean children. Genet Test Mol Biomark. 2013;17(4):301–6. doi:10.1089/gtmb.2012.0376.View ArticleGoogle Scholar
  17. Marazziti D, Baroni S, Masala I, Golia F, Consoli G, Massimetti G, Picchetti M, Catena Dell’osso M, Giannaccini G. Impulsivity, gender, and the platelet serotonin transporter in healthy subjects. Neuropsychiatr Dis Treat. 2010;6:9–15.PubMedPubMed CentralGoogle Scholar
  18. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. 2008;75(1):63–75. doi:10.1016/j.bcp.2007.06.043.View ArticlePubMedGoogle Scholar
  19. Coccaro EF, Lee R. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J Neural Transm. 2010;117(2):241–8. doi:10.1007/s00702-009-0359-x.View ArticlePubMedGoogle Scholar
  20. Glick A. The role of serotonin in impulsive aggression, suicide, and homicide in adolescents and adults: a literature review. Int J Adolesc Med Health. 2015;27(2):143–50. doi:10.1515/ijamh-2015-5003.View ArticlePubMedGoogle Scholar
  21. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003;66(9):1673–80. doi:10.1016/S0006-2952(03)00556-2.View ArticlePubMedGoogle Scholar
  22. Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry. 2005;10(10):944–9. doi:10.1038/sj.mp.4001698.View ArticlePubMedGoogle Scholar
  23. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer Ch, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knölker U, Friedel S, Schäfer H, Gross C, Hebebrand J, Warnke A, Lesch KP. Transmission disequilibrium of polymorphicvariants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry. 2005;10(12):1126–32. doi:10.1038/sj.mp.4001734.View ArticlePubMedGoogle Scholar
  24. Pereira Pde A, Romano-Silva MA, Bicalho MA, De Marco L, Correa H, de Campos SB, de Moraes EN, Torres KC, de Souza BR, de Miranda DM. Association between tryptophan hydroxylase-2 gene and late-onset depression. Am J Geriatr Psychiatry. 2011;19(9):825–9. doi:10.1097/JGP.0b013e31820eeb21.View ArticlePubMedGoogle Scholar
  25. Goenjian AK, Bailey JN, Walling DP, Steinberg AM, Schmidt D, Dandekar U, Noble EP. Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms. J Affect Disord. 2012;140(3):244–52. doi:10.1016/j.jad.2012.02.015.View ArticlePubMedGoogle Scholar
  26. Goenjian AK, Noble EP, Steinberg AM, Walling DP, Stepanyan ST, Dandekar S, Bailey JN. Association of COMT and TPH-2 genes with DSM-5 based PTSD symptoms. J Affect Disord. 2014;172C:472–8. doi:10.1016/j.jad.2014.10.034.Google Scholar
  27. Wrzosek M, Łukaszkiewicz J, Wrzosek M, Serafin P, Jakubczyk A, Klimkiewicz A, Matsumoto H, Brower KJ, Wojnar M. Association of polymorphisms in HTR2A, HTR1A and TPH2 genes with suicide attempts in alcohol dependence: a preliminary report. Psychiatry Res. 2011;190(1):149–51. doi:10.1016/j.psychres.2011.04.027.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Zupanc T, Pregelj P, Paska AV. Tryptophan hydroxylase 2 (TPH-2) single nucleotide polymorphisms, suicide, and alcohol-related suicide. Psychiatr Danub. 2013;25(Suppl 2):332–6.Google Scholar
  29. Perez-Rodriguez MM, Weinstein S, New AS, Bevilacqua L, Yuan Q, Zhou Z, Hodgkinson C, Goodman M, Koenigsberg HW, Goldman D, Siever LJ. Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatr Res. 2010;44(15):1075–81. doi:10.1016/j.jpsychires.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Zhang C, Li Z, Shao Y, Xie B, Du Y, Fang Y, Yu S. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci. 2011;43(3):406–11. doi:10.1007/s12031-010-9458-2.View ArticlePubMedGoogle Scholar
  31. Xu XM, Ding M, Pang H, Wang BJ. TPH2 gene polymorphisms in the regulatory region are associated with paranoid schizophrenia in Northern Han Chinese. Genet Mol Res. 2014;13(1):1497–507. doi:10.4238/2014.March.12.1.View ArticlePubMedGoogle Scholar
  32. Campos SB, Miranda DM, Souza BR, Pereira PA, Neves FS, Tramontina J, Kapczinski F, Romano-Silva MA, Correa H. Association study of tryptophan hydroxylase 2 gene polymorphisms in bipolar disorder patients with panic disorder comorbidity. Psychiatr Genet. 2011;21:106–11. doi:10.1097/YPG.0b013e328341a3a8.View ArticlePubMedGoogle Scholar
  33. Xiao PF, Cheng L, Wan Y, Sun BL, Chen ZZ, Zhang SY, Zhang CZ, Zhou GH, Lu ZH. An improved gel-based DNA microarray method for detecting single nucleotide mismatch. Electrophoresis. 2006;27(19):3904–15. doi:10.1002/elps.200500918.View ArticlePubMedGoogle Scholar
  34. Xiao P, Huang H, Zhou G, Lu Z. Gel immobilization of acrylamide-modified single-stranded DNA template for pyrosequencing. Electrophoresis. 2007;28(12):1903–12. doi:10.1002/elps.200600794.View ArticlePubMedGoogle Scholar
  35. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol. 2002;155(5):478–84.View ArticlePubMedGoogle Scholar
  36. Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Jiménez M, Galleguillos F, Bustamante ML. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder. Psychiatr Genet. 2010;20(1):25–30. doi:10.1097/YPG.0b013e328335125d.View ArticlePubMedGoogle Scholar
  37. Audero E, Mlinar B, Baccini G, Skachokova ZK, Corradetti R, Gross C. Suppression of serotonin neuron firing increases aggression in mice. J Neurosci. 2013;33(20):8678–88. doi:10.1523/JNEUROSCI.2067-12.2013.View ArticlePubMedGoogle Scholar
  38. Chen GL, Miller GM. Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(2):152–71. doi:10.1002/ajmg.b.32023.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Martel MM, Nikolas M, Jernigan K, Friderici K, Nigg JT. Diversity in pathways to common childhood disruptive behavior disorders. J Abnorm Child Psychol. 2012;40(8):1223–36. doi:10.1007/s10802-012-9646-3.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Brammer WA, Lee SS. Prosociality and negative emotionality mediate the association of serotonin transporter genotype with childhood ADHD and ODD. J Clin Child Adolesc Psychol. 2013;42(6):809–19. doi:10.1080/15374416.2013.840638.View ArticlePubMedGoogle Scholar
  41. Waider J, Araragi N, Gutknecht L, Lesch KP. Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective. Psychoneuroendocrinology. 2011;36(3):393–405. doi:10.1016/j.psyneuen.View ArticlePubMedGoogle Scholar
  42. Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Hwang JA, Kim YK. A case-control association study of serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(6):974–9. doi:10.1016/j.pnpbp.View ArticlePubMedGoogle Scholar
  43. Rocha FF, Alvarenga NB, Lage NV, Romano-Silva MA, Marco LA, Corrêa H. Associations between polymorphic variants of the tryptophan hydroxylase 2 gene and obsessive-compulsive disorder. Rev Bras Psiquiatr. 2011;33:176–80.View ArticlePubMedGoogle Scholar
  44. Carkaci-Salli N, Salli U, Tekin I, Hengst JA, Zhao MK, Gilman TL, Andrews AM, Vrana KE. Functional characterization of the S41Y (C2755A) polymorphism of tryptophan hydroxylase 2. J Neurochem. 2014;130(6):748–58. doi:10.1111/jnc.12779.View ArticlePubMedGoogle Scholar
  45. Gao J, Pan Z, Jiao Z, Li F, Zhao G, Wei Q, Pan F, Evangelou E. TPH2 gene polymorphisms and major depression–a meta-analysis. PLoS ONE. 2012;7(5):e36721. doi:10.1371/journal.pone.0036721.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Shen X, Wu Y, Qian M, Wang X, Hou Z, Liu Y, Sun J, Zhong H, Yang J, Lin M, Li L, Guan T, Shen Z, Yuan Y. Tryptophan hydroxylase 2 gene is associated with major depressive disorder in a female Chinese population. J Affect Disord. 2011;133(3):619–24. doi:10.1016/j.jad.2011.04.037.View ArticlePubMedGoogle Scholar
  47. Zupanc T, Pregelj P, Tomori M, Komel R, Paska AV. TPH2 polymorphisms and alcohol-related suicide. Neurosci Lett. 2011;490(1):78–81. doi:10.1016/j.neulet.2010.12.030.View ArticlePubMedGoogle Scholar
  48. Lazary J, Viczena V, Dome P, Chase D, Juhasz G, Bagdy G. Hopelessness, a potential endophenotpye for suicidal behavior, is influenced by TPH2 gene variants. Prog Neuropsychopharmacol Biol Psychiatry. 2012;36(1):155–60. doi:10.1016/j.pnpbp.2011.09.001.View ArticlePubMedGoogle Scholar
  49. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33(2):177–82. doi:10.1038/ng1071.View ArticlePubMedGoogle Scholar
  50. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–9. doi:10.1126/science.1069424.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2016

Advertisement

Behavioral and Brain Functions

ISSN: 1744-9081

Contact us